A nucleic acid aptamer FET biosensor
By adjusting the Debye length, specifically adjusting the passivation layer thickness and solution ionic strength to make it highly matched with nucleic acid aptamers, the problem of reduced detection sensitivity of FET biosensors in high-salt environments is solved, and the detection of small molecules is significantly improved responsiveness.
Patent Information
- Application Number
- CN202210216767.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2022-03-07
- Publication Date
- 2024-12-03
- Estimated Expiration
- 2042-03-07
AI Technical Summary
FET biosensors are limited by the Debye shielding mechanism in a physiological environment with high salt and high ionic strength, resulting in a reduced detection sensitivity, which is difficult to effectively solve the existing strategies.
By adjusting the Debye length, the specific method is to adjust the passivation layer thickness and solution ionic strength to highly match the nucleic acid aptamer, thereby improving the sensitivity of the FET biosensor.
By adjusting the Debye length, the sensitivity of FET biosensors to small molecule detection is significantly improved, the detection capability in high-salt environments is enhanced, and the sensitivity is significantly improved.
Smart Images

Figure CN114646674B_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of biosensors, and in particular to a method for improving the sensitivity of a nucleic acid aptamer FET biosensor. Background Art
[0002] Field effect transistor (FET) based biosensors have attracted great attention in the past few years due to their great role in drug discovery, disease diagnosis and environmental monitoring. FET biosensors have the advantages of small size, high sensitivity at ultra-low concentrations, high mechanical strength, and good solution stability, and play a vital role in POCT systems. The channel of FET is functionalized with a probe with target recognition function. The binding process of the probe and the target changes the surface potential of the channel and controls the number of carriers in the channel to open the channel. This change related to transconductance can significantly amplify the signal of target detection. FET has a similar function to ordinary electronic amplification circuits. Therefore, the charge on the channel surface and in the surrounding medium is crucial to the function of field effect transistors.
[0003] However, when FET devices are detected in solution, only charge changes close to the device surface can be detected, that is, the effective sensing distance depends on the Debye length (screening length of charge carriers in solution). In field effect transistors, the Debye length refers to the distance above the channel surface. Beyond this distance, the impact of local electric field changes rapidly decreases in terms of the ability to change the semiconductor channel surface potential and gate carriers. The Debye length greatly limits the application of FET biosensors in physiological environments with high salt and high ionic strength, and seriously reduces the performance of FET biosensors. In response to this Debye screening mechanism, existing strategies include synthesizing special channel materials with a wrinkled morphology to reduce the distance that the target moves to the material surface after binding, designing the receptor size so that its recognition process is within the Debye length, controlling the target binding mode, and adjusting the device measurement method to suppress the formation of a double layer. Summary of the invention
[0004] The purpose of the present invention is to provide a new method for improving the sensitivity of nucleic acid aptamer FET biosensor. The adjustment method is simple to operate and easy to implement.
[0005] The present invention achieves the above technical objectives through the following technical solutions:
[0006] The invention provides a method for improving the sensitivity of a nucleic acid aptamer FET biosensor. The method is achieved by adjusting the Debye length to make it highly matched with the nucleic acid aptamer.
[0007] Specifically, the Debye length is achieved by changing the thickness of the passivation layer and / or the ionic strength of the solution.
[0008] As an embodiment of the present invention, the adjustment of the thickness of the passivation layer includes the following steps:
[0009] Calculate the range of the thickness of the passivation layer of the biosensor to be prepared according to the existing data records and the dielectric constant formula of the passivation layer;
[0010] FET sensors with different passivation layer thicknesses were prepared and their sensitivity was verified to determine the optimal passivation layer thickness.
[0011] As an embodiment of the present invention, the thickness of the passivation layer is achieved by controlling the parameters of spin coating.
[0012] Specifically, the parameters of spin coating include the spin coating speed and number of times.
[0013] As an embodiment of the present invention, the adjustment of the solution ionic strength comprises the following steps:
[0014] Calculate the range of ionic strength of the buffer system of the biosensor test solution to be prepared according to existing data records and the Debye length formula;
[0015] Prepare buffer systems with different ionic strengths.
[0016] As an embodiment of the present invention, when the target of the biosensor is dopamine, serotonin, or glucose, the detection responsiveness reaches a maximum value when the Debye length is 2.19 nm.
[0017] As an embodiment of the present invention, when the target of the biosensor is dopamine, serotonin, or glucose, the detection responsiveness reaches a maximum value when the thickness of the passivation layer is 5.0 um.
[0018] The inventors found in their research that when the Debye length and the probe height are adjusted to be equivalent, the sensitivity of the FET biosensor is the highest; the inventors further deduced through the dielectric constant formula and the Debye length formula that changing the thickness of the passivation layer and / or the solution ionic strength during detection can achieve the adjustment of the Debye length, and finally verified the above conclusion through a series of specific experimental cases and theoretical calculations of the effect of the effective charge amount brought about by the conformational changes of the nucleic acid aptamer near the Debye length on the sensitivity of the nucleic acid aptamer-FET biosensor.
[0019] The invention adopts commercial photoresist AZ5214 to control the thickness of the passivation layer, adjusts the Debye length of the test environment to match the height before and after the conformational change of the nucleic acid aptamer, and optimizes the sensitivity of the FET biosensor to small molecule detection. The passivation layer adopts commercial products with stable performance, and its thickness can be accurately controlled by the spin coating speed and the number of spin coating times. At the same time, the passivation layer can improve the stability of the biosensor in the solution test environment; or the Debye length can be adjusted by adjusting the solution ion strength during detection, thereby realizing the adjustment of sensitivity, and the adjustment is simple and easy to achieve. BRIEF DESCRIPTION OF THE DRAWINGS
[0020] Figure 1 The diagram is a diagram showing the effect of different passivation layer thicknesses and ionic strengths on the sensitivity of the FET biosensor based on serotonin nucleic acid aptamers in Example 1 of the present invention;
[0021] Figure 2 This is a diagram showing the effect of different passivation layer thicknesses and ionic strengths on the sensitivity of the FET biosensor based on dopamine aptamers in Example 2 of the present invention;
[0022] Figure 3 This is a diagram showing the effect of different passivation layer thicknesses and ionic strengths on the sensitivity of the FET biosensor based on glucose aptamers in Example 3 of the present invention;
[0023] Figure 4 The influence principle of Debye length on the number of channel carriers before and after the conformational change of nucleic acid aptamer obtained by theoretical calculation, the height of serotonin probe before and after binding to the target obtained by theoretical calculation and the influence results of different Debye lengths on serotonin detection. DETAILED DESCRIPTION
[0024] The present invention is further described in detail below in conjunction with specific embodiments so that those skilled in the art can understand the present invention more clearly.
[0025] The following embodiments are only used to illustrate the present invention and are not intended to limit the scope of the present invention. Based on the specific embodiments of the present invention, all other embodiments obtained by ordinary technicians in the field without creative work belong to the protection scope of the present invention.
[0026] In the examples of the present invention, unless otherwise specified, all raw material components are commercially available products well known to those skilled in the art; in the examples of the present invention, unless otherwise specified, the technical means used are conventional means well known to those skilled in the art.
[0027] The target-corresponding nucleic acid aptamer sequences involved in the following examples are as follows:
[0028]
[0029] Example 1
[0030] The purpose of this example is to study the effects of different passivation layer thicknesses and ionic strengths on the sensitivity of FET biosensors based on serotonin nucleic acid aptamers. The specific methods are as follows:
[0031] S1. Calculate the range of the thickness of the passivation layer of the biosensor to be prepared according to the existing data records and the dielectric constant formula of the passivation layer. The specific calculation process is as follows:
[0032] According to the data, the electrostatic force constant K is 8.98×10 9 Nm 2 / C 2 , the vacuum dielectric constant ε0 is 8.85×10 -12 F / m, Boltzmann constant KB is 1.38×10 -23 J / K, temperature (Kelvin) T is 293.16K, Avogadro number N a 6.02×10 23 , the basic charge e is 1.60×10 -19 C;
[0033] The test results show that the capacitance per unit area of the passivation layer C / S is 58.3 pF / mm 2 ;
[0034] Substituting the above data into the dielectric constant In the formula, the relationship between the thickness of the passivation layer and its dielectric constant is obtained;
[0035] According to the data, the vacuum dielectric constant ε0 is 8.85×10 -12 F / m, Boltzmann constant K B 1.38×10 -23 J / K, temperature (Kelvin) T is 293.16 K, Avogadro number N a 6.02×10 23 , the basic charge e is 1.60×10 -19 C;
[0036] The above data and dielectric constant Substitute into the Debye length formula In the figure, the relationship between the thickness of the passivation layer d and the Debye length λD is obtained. Considering that the number of bases of the nucleic acid aptamer is 40-50 bases, it is reasonable to speculate that the height range of the aptamer is 1-3 nm. It is calculated that when the Debye length is approximately 1-3 nm, the thickness range of the passivation layer is 1.0-9.3 μm; where ε0, εr, KB, T, Na, e and I represent the vacuum dielectric constant, the passivation layer dielectric constant, the Boltzmann constant, the temperature (Kelvin), the Avogadro number, the elementary charge and the ionic strength.
[0037] S2, calculate the ion intensity range of the target to be tested according to the existing data records and the Debye length formula. The specific calculation process is as follows:
[0038] According to the data, the vacuum dielectric constant ε0 is 8.85×10 -12 F / m, water dielectric constant ε r is 81.50, the Boltzmann constant K B 1.38×10 -23 J / K, temperature (Kelvin) T is 293.16 K, Avogadro number Na is 6.02×10 23 , the basic charge e is 1.60×10 -19 C,
[0039] Substituting the above data into the Debye length formula The ionic strength range of the target to be tested is 0.16-162.74 mM; r , K B , T, N a , e, and I represent the dielectric constant of vacuum, dielectric constant of water, Boltzmann constant, temperature (Kelvin), Avogadro number, elementary charge, and ionic strength.
[0040] S3, preparing serotonin aptamer-based FET biosensors with different passivation layer thicknesses, the specific steps are as follows:
[0041] A 0.1M indium nitrate aqueous solution was spin-coated on a 2×2cm silicon wafer at a rotation speed of 6000 rpm. After annealing at 350°C for 3h, an amorphous In2O3 semiconductor film with a thickness of only 6nm was obtained. Then, the three electrodes (source, drain and gate) of FET were deposited on the 2×2cm silicon wafer through a photolithography coating process to prepare a 12 In2O3 FET device array. The surface of In2O3 was silanized by 3-aminopropyltrimethoxysilane (APTMS) vapor deposition under vacuum at 40°C. Then, the speed of the coating machine was set from 2000 rpm to 9000 rpm, and the number of spin coating was 1-4 times in different combinations. The photoresist AZ5214 was spin-coated onto the device surface as a passivation layer and its thickness was controlled. The AZ5214 was subjected to a standard laser direct writing process to expose the silanized In2O3 channel window as the probe fixation and target recognition site. Then, m-maleimidobenzoyl-N-hydroxysuccinimide ester (MBS) was used as a linker molecule to modify 1mM thiol-terminated nucleic acid aptamer on the silanized In2O3 for 12h. After repeated washing with deionized water and drying with N2, the passivation layer thicknesses were 1.0, 3.5, 5.0, 6.6, and 9.3μm, respectively (corresponding to Debye lengths of 0.98, 1.83, and 2.3μm, respectively). 2.19, 2.52, 2.93 nm) of serotonin nucleic acid aptamer-based FET biosensor.
[0042] S4, prepare test solutions with ionic strengths of 162.74 mM, 16.27 mM, 1.62 mM, 0.48 mM, and 0.16 mM, respectively. The specific preparation method is as follows: First, prepare a buffer system with an ionic strength of 162.74 mM, wherein the components include 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, and 1.8 mM KH2PO4. Then dilute to buffers with ionic strengths of 16.27 mM, 1.62 mM, 0.48 mM, and 0.16 mM, respectively, and then use buffers with different ionic strengths to prepare serotonin test solutions with concentrations of 1 fM, 10 fM, 100 fM, 1 pM, 10 pM, 100 pM, 1 nM, and 10 nM, respectively.
[0043] S5, the FET biosensors with different passivation layer thicknesses prepared in step S3 are tested on a probe station (CRX-6.5K, Lake Shore) and a semiconductor analyzer (4200-SCS, Keithley), and the test solution in step S4 is fixed directly above the FET sensor through a PDMS ring with a diameter of 3 mm. At the same time, PDMS can isolate the FET sensor arrays on the same silicon wafer during the test to make them independent of each other. In the test of ionic strength regulating Debye length, the solution ionic strength adjustment range is between 0.16-162.74 mM. The transfer specificity curve current changes of the FET sensor at serotonin concentrations of 1 fM to 10 nM are tested at different Debye lengths, and all test solutions are controlled at pH 7.4.
[0044] Experimental principles and test results are as follows Figure 1 As shown, Figure 1 a is a schematic diagram of the passivation layer thickness adjusting the Debye length. Figure 1 b is the serotonin detection responsivity of the passivation layer thickness adjusting the Debye length, Figure 1 c is a schematic diagram of the Debye length regulation by solution ionic strength. Figure 1 d is the serotonin detection response of the Debye length adjusted by ionic strength.
[0045] Example 2
[0046] The purpose of this example is to study the effects of different passivation layer thicknesses and ionic strengths on the sensitivity of FET biosensors based on dopamine nucleic acid aptamers. The specific methods are as follows:
[0047] According to the data, the electrostatic force constant K is 8.98×10 9 Nm 2 / C 2 ;
[0048] The test results show that the capacitance per unit area C / S is 58.3 pF / mm 2 ,
[0049] Substituting the above data into the dielectric constant formula The thickness of the passivation layer is in the range of 1.0 to 9.3 μm.
[0050] S2, calculate the ion intensity range of the target to be tested according to the existing data records and the Debye length formula. The specific calculation process is as follows:
[0051] According to the data, the vacuum dielectric constant ε0 is 8.85×10 -12 F / m, Boltzmann constant K B 1.38×10 -23J / K, temperature (Kelvin) T is 293.16 K, Avogadro number Na is 6.02×10 23 , the basic charge e is 1.60×10 -19 C,
[0052] Substituting the above data into the Debye length formula In the experiment, the ionic strength range of the target to be tested was 0.16-162.74 mM.
[0053] S3, preparing FET biosensors based on dopamine nucleic acid aptamers with different passivation layer thicknesses, the specific steps are as follows:
[0054] A 0.1M indium nitrate aqueous solution was spin-coated on a 2×2cm silicon wafer at a rotation speed of 6000 rpm. After annealing at 350°C for 3h, an amorphous In2O3 semiconductor film with a thickness of only 6nm was obtained. Then, the three electrodes (source, drain and gate) of FET were deposited on the 2×2cm silicon wafer through a photolithography coating process to prepare a 12 In2O3 FET device array. The surface of In2O3 was silanized by 3-aminopropyltrimethoxysilane (APTMS) vapor deposition under vacuum at 40°C. Then, the speed of the coating machine was set from 2000 rpm to 9000 rpm, and the number of spin coating was 1-4 times in different combinations. The photoresist AZ5214 was spin-coated onto the device surface as a passivation layer and its thickness was controlled. The AZ5214 was subjected to a standard laser direct writing process to expose the silanized In2O3 channel window as the probe fixation and target recognition site. Then, m-maleimidobenzoyl-N-hydroxysuccinimide ester (MBS) was used as a linker molecule to modify 1mM thiol-terminated nucleic acid aptamer on the silanized In2O3 for 12h. After repeated washing with deionized water and drying with N2, the passivation layer thicknesses were 1.0, 3.5, 5.0, 6.6, and 9.3μm, respectively (corresponding to Debye lengths of 0.98, 1.83, and 1.3μm, respectively). 2.19, 2.52, 2.93 nm) of dopamine nucleic acid aptamer-based FET biosensor.
[0055] S4, prepare test solutions with ionic strengths of 162.74 mM, 16.27 mM, 1.62 mM, 0.48 mM, and 0.16 mM, respectively. The specific preparation method is as follows: First, prepare a buffer system with an ionic strength of 162.74 mM, wherein the components include 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, and 1.8 mM KH2PO4. Then dilute to buffers with ionic strengths of 16.27 mM, 1.62 mM, 0.48 mM, and 0.16 mM, respectively, and then use buffers with different ionic strengths to prepare dopamine test solutions with concentrations of 1 fM, 10 fM, 100 fM, 1 pM, 10 pM, 100 pM, 1 nM, and 10 nM, respectively.
[0056] S5, the FET biosensors with different passivation layer thicknesses prepared in step S3 are tested on a probe station (CRX-6.5K, Lake Shore) and a semiconductor analyzer (4200-SCS, Keithley). The test solution in step S4 is fixed directly above the FET sensor through a PDMS ring with a diameter of 3 mm. At the same time, PDMS can isolate the FET sensor arrays on the same silicon wafer during the test to make them independent of each other. In the test of adjusting the Debye length by ionic strength, the solution ionic strength adjustment range is between 0.16-162.74 mM. The transfer specificity curve current changes of the FET sensor at dopamine concentrations of 1 fM to 10 nM were tested at different Debye lengths, and all test solutions were controlled at pH 7.4. The test results are as follows Figure 2 shown.
[0057] Example 3
[0058] The purpose of this example is to study the effects of different passivation layer thicknesses and ionic strengths on the sensitivity of FET biosensors based on glucose nucleic acid aptamers. The specific methods are as follows:
[0059] S1. Calculate the range of the thickness of the passivation layer of the biosensor to be prepared according to the existing data records and the dielectric constant formula of the passivation layer. The specific calculation process is as follows:
[0060] According to the data, the electrostatic force constant K is 8.98×10 9 Nm 2 / C 2 ;
[0061] The test results show that the capacitance per unit area C / S is 58.3 pF / mm 2 ,
[0062] Substituting the above data into the dielectric constant formula The thickness of the passivation layer is in the range of 1.0 to 9.3 μm.
[0063] S2, calculate the ion intensity range of the target to be tested according to the existing data records and the Debye length formula. The specific calculation process is as follows:
[0064] According to the data, the vacuum dielectric constant ε0 is 8.85×10 -12 F / m, Boltzmann constant K B 1.38×10 -23 J / K, temperature (Kelvin) T is 293.16 K, Avogadro number Na is 6.02×10 23 , the basic charge e is 1.60×10 -19 C,
[0065] Substituting the above data into the Debye length formula In the experiment, the ionic strength range of the target to be tested was 0.16-162.74 mM.
[0066] S3, preparing FET biosensors based on glucose nucleic acid aptamers with different passivation layer thicknesses, the specific steps are as follows:
[0067] A 0.1M indium nitrate aqueous solution was spin-coated on a 2×2cm silicon wafer at a rotation speed of 6000 rpm. After annealing at 350°C for 3h, an amorphous In2O3 semiconductor film with a thickness of only 6nm was obtained. Then, the three electrodes (source, drain and gate) of FET were deposited on the 2×2cm silicon wafer through a photolithography coating process to prepare a 12 In2O3 FET device array. The surface of In2O3 was silanized by 3-aminopropyltrimethoxysilane (APTMS) vapor deposition under vacuum at 40°C. Then, the speed of the coating machine was set from 2000 rpm to 9000 rpm, and the number of spin coating was 1-4 times in different combinations. The photoresist AZ5214 was spin-coated onto the device surface as a passivation layer and its thickness was controlled. The AZ5214 was subjected to a standard laser direct writing process to expose the silanized In2O3 channel window as the probe fixation and target recognition site. Then, m-maleimidobenzoyl-N-hydroxysuccinimide ester (MBS) was used as a linker molecule to modify 1mM thiol-terminated nucleic acid aptamer on the silanized In2O3 for 12h. After repeated washing with deionized water and drying with N2, the passivation layer thicknesses were 1.0, 3.5, 5.0, 6.6, and 9.3μm, respectively (corresponding to Debye lengths of 0.98, 1.83, and 2.3μm, respectively). 2.19, 2.52, 2.93 nm) of FET biosensor based on glucose nucleic acid aptamer.
[0068] S4, prepare test solutions with ionic strengths of 162.74 mM, 16.27 mM, 1.62 mM, 0.48 mM, and 0.16 mM, respectively. The specific preparation method is as follows: First, prepare a buffer system with an ionic strength of 162.74 mM, wherein the components include 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, and 1.8 mM KH2PO4. Then dilute the buffers to ionic strengths of 16.27 mM, 1.62 mM, 0.48 mM, and 0.16 mM, respectively, and then use buffers with different ionic strengths to prepare glucose test solutions with concentrations of 1 fM, 10 fM, 100 fM, 1 pM, 10 pM, 100 pM, 1 nM, and 10 nM, respectively.
[0069] S5, the FET biosensors with different passivation layer thicknesses prepared in step S3 are tested on a probe station (CRX-6.5K, Lake Shore) and a semiconductor analyzer (4200-SCS, Keithley). The test solution in step S4 is fixed directly above the FET sensor through a PDMS ring with a diameter of 3 mm. At the same time, PDMS can isolate the FET sensor arrays on the same silicon wafer during the test to make them independent of each other. In the test of adjusting the Debye length by ionic strength, the solution ionic strength adjustment range is between 0.16-162.74 mM. The transfer specificity curve current changes of the FET sensor at glucose concentrations ranging from 1 fM to 10 nM were tested at different Debye lengths, and all test solutions were controlled at pH 7.4. The test results are shown in the figure below. Figure 3 shown.
[0070] Effect verification and data statistics:
[0071] Adjusting the Debye length of the passivation layer can significantly improve the detection responsiveness to a variety of small molecule targets. We propose that when the Debye length and the conformational change of the aptamer are at a matching value, the negative charge carried by the aptamer after the conformational change is higher than the Debye length and is in a shielded state. At the same time, it brings about a decrease or increase in the number of effective charges interacting with the carriers of the channel material, which greatly affects the electrical properties of the channel, that is, a significant improvement in the target detection responsiveness, such as Figure 4 abc. At the same time, the theoretical calculation method is adopted ( Figure 4 de), the calculation formula is Where △I is the current change value, I max is the maximum value of theoretical current change, l is the theoretical probe height, λ DThe calculated theoretical heights of the aptamer before and after the conformational change are 1.86 nm and 2.28 nm, which is completely consistent with the 2.19 nm Debye length being between the heights before and after the conformational change. This verifies the mechanism proposed by us that the Debye length is highly matched with the conformational change of the aptamer to increase the change in the effective charge quantity and improve the target detection responsiveness. Figure 4 f is the detection responsivity of the serotonin FET biosensor at different Debye lengths, which is consistent with the calculation results and the maximum responsivity is achieved in the environment of 2.19 nm Debye length.
[0072] Through three examples of the detection results of three biological molecular targets, serotonin, dopamine and glucose, and the theoretical calculation of the height of the nucleic acid aptamer probe before and after the conformational change, it can be concluded that the core of this optimization of detection responsiveness lies in adjusting the Debye length of the test system to match the height of the nucleic acid aptamer probe. For nucleic acid aptamer probes of different heights of other biological molecules, the inventors have found through extensive research that it is also only necessary to adjust different Debye lengths, and the mechanism of optimizing detection responsiveness is also applicable.
[0073] It is necessary to point out that the above embodiments are limited to further elaboration and explanation of the technical solution of the present invention, and are not further limitations of the technical solution of the present invention. The method of the present invention is only a preferred implementation scheme, and is not used to limit the protection scope of the present invention. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.
Claims
1. A nucleic acid aptamer FET biosensor, characterized in that: The nucleic acid aptamer of the biosensor is serotonin. The Debye length of the biosensor is 2.19 nm, which is between the heights before and after the conformational change of the nucleic acid aptamer. The Debye length is equivalent to the probe height. The sequence information of the nucleic acid aptamer is as follows: The serotonin concentrations were 1 nM, 10 nM and 100 pM, respectively.
2. The nucleic acid aptamer FET biosensor according to claim 1, characterized in that: The Debye length is achieved by varying the thickness of the passivation layer and / or the ionic strength of the solution.
3. The nucleic acid aptamer FET biosensor according to claim 2, characterized in that: The thickness of the passivation layer is achieved by controlling the parameters of spin coating.
4. The nucleic acid aptamer FET biosensor according to claim 3, characterized in that: The parameters of spin coating include the spin coating speed and number of times.
Citation Information
Patent Citations
Electrochemical unlabeled nucleic acid detection method
JP2020058244A
Biomolecule sensing method using Field Effect Transistor with controllable Debye length
US20050191683A1
Detection device and target detection method using the same
US20180238867A1
Debye length modulation
US20190094174A1
Stem-loop receptor-based field-effect transistor sensor devices for small-molecule target detection under physiological salt concentrations
US20210223240A1
